Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mustang Bio Inc (MBIO)

Mustang Bio Inc (MBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Next-Gen Cancer Treatments Gain Steam Amid Oncology Industry Shakeups

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – Cancer rates are climbing across the U.S., with stark disparities from state to state. Recent CDC data...

ONCY : 0.9606 (-0.44%)
INAB : 2.50 (+1.21%)
ONC.TO : 1.42 (+2.16%)
TNGX : 11.79 (+21.92%)
MBIO : 1.1300 (+3.67%)
ELVN : 15.47 (+2.18%)
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:MBIO),(NASDAQ:VSTM),(NASDAQ:CRDF),(NASDAQ:AZN) EQNX::TICKER_END

ONCY : 0.9606 (-0.44%)
AZN : 95.16 (+0.21%)
ONC.TO : 1.42 (+2.16%)
VSTM : 7.64 (+11.05%)
CRDF : 3.21 (+8.08%)
MBIO : 1.1300 (+3.67%)
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies

ONCY : 0.9606 (-0.44%)
AZN : 95.16 (+0.21%)
ONC.TO : 1.42 (+2.16%)
VSTM : 7.64 (+11.05%)
CRDF : 3.21 (+8.08%)
MBIO : 1.1300 (+3.67%)
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma

FBIO : 4.27 (+1.43%)
MBIO : 1.1300 (+3.67%)
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement

FBIO : 4.27 (+1.43%)
MBIO : 1.1300 (+3.67%)
Mustang Bio Announces Sale of Fixed Assets and Exit of Facility

MBIO : 1.1300 (+3.67%)
Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement

MBIO : 1.1300 (+3.67%)
Mustang Bio Announces Closing of $8 Million Public Offering

MBIO : 1.1300 (+3.67%)
Mustang Bio Announces Pricing of $8 Million Public Offering

MBIO : 1.1300 (+3.67%)
Mustang Bio Announces Reverse Stock Split

MBIO : 1.1300 (+3.67%)

Barchart Exclusives

Stocks Slip Before the Open as Investors Weigh Trump Policy Shifts, U.S. Economic Data on Tap
March S&P 500 E-Mini futures (ESH26) are down -0.19%, and March Nasdaq 100 E-Mini futures (NQH26) are down -0.28% this morning, pointing to further losses on Wall Street after U.S. President Donald Trump followed his intervention in Venezuela with actions targeting the U.S. housing and defense industries. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar